-
2027 Endurance: TCS London Marathon Application
… & RELEASE OF LIABILITY I am solely responsible for my own health and safety. I represent and warrant that I am …
-
News in Context: Mixed Results from Two Experimental Drugs Targeting Alpha-Synuclein
December 20, 2024
… from two Phase II clinical trials of two respective experimental drugs designed to slow the progression of PD by … things like daily living activities, movement function and mental state. Results from the PADOVA Phase II study were … recall the beta-amyloid protein, which is similarly fundamental in Alzheimer’s disease. In the Alzheimer’s field, …
-
Memory and Thinking Changes in Parkinson’s Disease
… dimensionally (visuospatial skills) examples: making a mental map to walk around the neighborhood and back, judging …
-
Terms & Conditions
… website as a substitute for consultations with qualified health care professionals who are familiar with individual … consultation with a patient’s physician or other qualified health care professionals who are familiar with the individual’s specific health situation. The Foundation makes no representations …
-
The Michael J. Fox Foundation Announces Parkinson's Disease Trial Recruitment Innovation Program
May 2, 2017
… Israel Deaconess Medical Center in Boston, MA; and Oregon Health and Science University in Portland, OR. Centers were … $700 million in research to date, the Foundation has fundamentally altered the trajectory of progress toward a cure. …
-
The Michael J. Fox Foundation Partners with Cohen Veterans Bioscience on BRAIN Commons, Harnessing the Power of Big Data for Brain Diseases
October 11, 2018
… (PPMI), BioFIND, the LRRK2 Cohort Consortium, its digital health portfolio and other Parkinson’s disease cohorts. “The … $800 million in research to date, the Foundation has fundamentally altered the trajectory of progress toward a cure. …